Loading page...
Loading page...
Loading page...
.png&w=3840&q=75)
As a world leader in the manufacture and supply of very high purity HFA medical propellants, Orbia Fluor & Energy Materials produces to the most demanding industry standards at dedicated facilities. Zephex® medical propellants are used in over two thirds of the world’s metered dose inhalers (MDIs).
This commitment to the highest levels of medical propellant quality is supported by a detailed understanding of customer needs and backed by the support of our experienced teams with many years of technical expertise.
We’re proud to support 100 million patients in accessing life-saving medication every year.
A sustainable, low-GWP medical propellant that has been developed by Orbia Fluor & Energy Materials over several years; Zephex® 152a is for use in metered dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and COPD.
Relied upon by leading organizations within the MDI space for over thirty years, Zephex® 134a is by far the most widely used medical propellant in the world.
Produced to our exacting, industry-leading standards, Zephex® 227ea offers performance characteristics complementary to Zephex® 134a.

In supporting our industry partners, we’re helping the industry navigate the F-Gas regulations throughout the transition to low-GWP propellants.
We're dedicated to protecting the continuation of supply of Zephex® 134a throughout the low-GWP transition; ensuring patients worldwide retain access to lifesaving medicine.
We are more than just our medical propellant. We are a supporting partner to the industry, helping with formulation services, support on the low-GWP transition and via our extensive lab services.
Our formulation services are designed to support early-stage development studies specialising in HFA-152a with internal capability to formulate and test pMDI products at bench and pilot (5L) scale.
.jpeg&w=3840&q=75)

Orbia Fluor & Energy Materials operates Technology Centers within key regions to enable R&D excellence across its business units.
Within the Pharma Business Unit, our Cheshire (UK) technology center serves as the key technology hub, positioned as our core medical propellants applications lab. It’s home to R&D specialists and technical experts bringing the low-GWP transition to life.
Zephex® propellants are manufactured at our industry leading facilities where all products are subject to a comprehensive quality control processes involving eleven separate tests to confirm purity and quality.
Dedicated stainless steel containers are used for the supply of Zephex® at manufacturing scale, eliminating problems associated with conventional packaging common to the rest of the industry. A number of steps are taken to ensure the quality of each package we supply, including security tagging with a unique number recorded on the Certificate of Analysis. This certificate contains a hologram mark to assure customers they are receiving only pure Zephex® quality.
Orbia Fluor & Energy Materials´ detailed understanding of the needs, standards and regulatory requirements of our pharmaceutical customers combined with expertise in fluorine chemistry and chemical handling makes us unique in the manufacture of propellants for pharmaceutical uses.

Here you’ll find further information on our terms and conditions of sale associated with our Pharma business unit.
Zephex® – Channelling over 30 years of experience into the future of medical propellants in MDIs

Do you have a question regarding medical propellants for one of our experts?

Here you can download additional support materials for our medical propellants and other informative resources such as flyers, white papers and guides.
.png&w=3840&q=75)
As a world leader in the manufacture and supply of very high purity HFA medical propellants, Orbia Fluor & Energy Materials produces to the most demanding industry standards at dedicated facilities. Zephex® medical propellants are used in over two thirds of the world’s metered dose inhalers (MDIs).
This commitment to the highest levels of medical propellant quality is supported by a detailed understanding of customer needs and backed by the support of our experienced teams with many years of technical expertise.
We’re proud to support 100 million patients in accessing life-saving medication every year.
A sustainable, low-GWP medical propellant that has been developed by Orbia Fluor & Energy Materials over several years; Zephex® 152a is for use in metered dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and COPD.
Relied upon by leading organizations within the MDI space for over thirty years, Zephex® 134a is by far the most widely used medical propellant in the world.
Produced to our exacting, industry-leading standards, Zephex® 227ea offers performance characteristics complementary to Zephex® 134a.

In supporting our industry partners, we’re helping the industry navigate the F-Gas regulations throughout the transition to low-GWP propellants.
We're dedicated to protecting the continuation of supply of Zephex® 134a throughout the low-GWP transition; ensuring patients worldwide retain access to lifesaving medicine.
We are more than just our medical propellant. We are a supporting partner to the industry, helping with formulation services, support on the low-GWP transition and via our extensive lab services.
Our formulation services are designed to support early-stage development studies specialising in HFA-152a with internal capability to formulate and test pMDI products at bench and pilot (5L) scale.
.jpeg&w=3840&q=75)

Orbia Fluor & Energy Materials operates Technology Centers within key regions to enable R&D excellence across its business units.
Within the Pharma Business Unit, our Cheshire (UK) technology center serves as the key technology hub, positioned as our core medical propellants applications lab. It’s home to R&D specialists and technical experts bringing the low-GWP transition to life.
Zephex® propellants are manufactured at our industry leading facilities where all products are subject to a comprehensive quality control processes involving eleven separate tests to confirm purity and quality.
Dedicated stainless steel containers are used for the supply of Zephex® at manufacturing scale, eliminating problems associated with conventional packaging common to the rest of the industry. A number of steps are taken to ensure the quality of each package we supply, including security tagging with a unique number recorded on the Certificate of Analysis. This certificate contains a hologram mark to assure customers they are receiving only pure Zephex® quality.
Orbia Fluor & Energy Materials´ detailed understanding of the needs, standards and regulatory requirements of our pharmaceutical customers combined with expertise in fluorine chemistry and chemical handling makes us unique in the manufacture of propellants for pharmaceutical uses.

Here you’ll find further information on our terms and conditions of sale associated with our Pharma business unit.
Zephex® – Channelling over 30 years of experience into the future of medical propellants in MDIs

Do you have a question regarding medical propellants for one of our experts?

Here you can download additional support materials for our medical propellants and other informative resources such as flyers, white papers and guides.